193 related articles for article (PubMed ID: 30525267)
1. Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer.
Sutherland S; Meiser B; Kaur R; Mitchell G; Kirk J; Peate M; Tim Wong WK; Goodwin A
Breast J; 2019 Jan; 25(1):34-40. PubMed ID: 30525267
[TBL] [Abstract][Full Text] [Related]
2. Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.
Chen Y; Peate M; Kaur R; Meiser B; Wong T; Kirk J; Ward RL; Goodwin A; Macrae F; Hiller J; Trainer AH; Mitchell G
Fam Cancer; 2017 Jan; 16(1):99-109. PubMed ID: 27677266
[TBL] [Abstract][Full Text] [Related]
3. Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes.
Smith SG; Foy R; McGowan JA; Kobayashi LC; de Censi A; DeCensi A; Brown K; Side L; Cuzick J
Br J Gen Pract; 2017 Jun; 67(659):e414-e427. PubMed ID: 28193617
[TBL] [Abstract][Full Text] [Related]
4. Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in France.
Larue F; Colleau SM; Fontaine A; Brasseur L
Cancer; 1995 Dec; 76(11):2375-82. PubMed ID: 8635046
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
[TBL] [Abstract][Full Text] [Related]
6. An exploration of Australian psychologists' role in assessing women considering risk-reducing or contralateral prophylactic mastectomy.
Braude L; Laidsaar-Powell R; Gilchrist J; Kirsten L; Juraskova I
Breast; 2017 Apr; 32():105-111. PubMed ID: 28135658
[TBL] [Abstract][Full Text] [Related]
7. Are Future Radiation Oncologists Equipped With the Knowledge to Manage Elderly Patients With Cancer?
Morris L; Thiruthaneeswaran N; Lehman M; Hasselburg G; Turner S
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):743-747. PubMed ID: 28258899
[TBL] [Abstract][Full Text] [Related]
8. Prescription of tamoxifen for breast cancer prevention by primary care physicians.
Armstrong K; Quistberg DA; Micco E; Domchek S; Guerra C
Arch Intern Med; 2006 Nov; 166(20):2260-5. PubMed ID: 17101945
[TBL] [Abstract][Full Text] [Related]
9. Utilisation of geriatric assessment in oncology - a survey of Australian medical oncologists.
To THM; Soo WK; Lane H; Khattak A; Steer C; Devitt B; Dhillon HM; Booms A; Phillips J
J Geriatr Oncol; 2019 Mar; 10(2):216-221. PubMed ID: 30041979
[TBL] [Abstract][Full Text] [Related]
10. Oncologist provision of smoking cessation support: A national survey of Australian medical and radiation oncologists.
Day FL; Sherwood E; Chen TY; Barbouttis M; Varlow M; Martin J; Weber M; Sitas F; Paul C
Asia Pac J Clin Oncol; 2018 Dec; 14(6):431-438. PubMed ID: 29706029
[TBL] [Abstract][Full Text] [Related]
11. The development of a template for psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study.
Braude L; Kirsten L; Gilchrist J; Juraskova I
Psychooncology; 2018 Oct; 27(10):2349-2356. PubMed ID: 29966172
[TBL] [Abstract][Full Text] [Related]
12. Faculty of Radiation Oncology survey of work practices.
Stevens G; Berry M; Firth I
Australas Radiol; 1999 May; 43(2):233-42. PubMed ID: 10901908
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Chlebowski RT; Col N; Winer EP; Collyar DE; Cummings SR; Vogel VG; Burstein HJ; Eisen A; Lipkus I; Pfister DG;
J Clin Oncol; 2002 Aug; 20(15):3328-43. PubMed ID: 12149307
[TBL] [Abstract][Full Text] [Related]
14. Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists.
Ellis PM; Butow PN; Simes RJ; Tattersall MH; Dunn SM
Aust N Z J Surg; 1999 Jul; 69(7):486-91. PubMed ID: 10442918
[TBL] [Abstract][Full Text] [Related]
15. Topical estrogen prescribing patterns for urogenital atrophy among women with breast cancer: results of a national provider survey.
Richter LA; Han J; Bradley S; Lynce FC; Willey SC; Tefera E; Pollack CE
Menopause; 2019 Jul; 26(7):714-719. PubMed ID: 30939535
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen in cancer therapy: minireview.
Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
[TBL] [Abstract][Full Text] [Related]
17. Oncology health professionals' attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer.
Burcher S; Meiser B; Mitchell G; Saunders C; Rahman B; Tucker K; Barlow-Stewart K; Watts K; Gleeson M; Kirk J
Per Med; 2013 Jul; 10(5):431-440. PubMed ID: 29758836
[TBL] [Abstract][Full Text] [Related]
18. A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.
Zdenkowski N; Butow P; Mann GB; Fewster S; Beckmore C; Isaacs R; Douglas C; Boyle FM
Intern Med J; 2016 Jun; 46(6):677-83. PubMed ID: 26929045
[TBL] [Abstract][Full Text] [Related]
19. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
[TBL] [Abstract][Full Text] [Related]
20. Barriers, beliefs and practice patterns for breast cancer reconstruction: A provincial survey.
Coroneos CJ; Roth-Albin K; Rai AS; Rai AS; Voineskos SH; Brouwers MC; Avram R; Heller B
Breast; 2017 Apr; 32():60-65. PubMed ID: 28038321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
